课题基金 / 基金详情

Probing into low-density lipoprotein receptor-related protein (LPR)-1-independent peptide transcytosis mechanisms

Probing into low-density lipoprotein receptor-related protein (LPR)-1-independent peptide transcytosis mechanisms
低密度脂蛋白受体相关蛋白(LPR)-1独立肽转胞吞机制探讨
批准号:
445033-2012
负责人:
Annabi, Borhane
金额:
$28.05万
依托单位国家:
加拿大
项目类别:
Collaborative Research and Development Grants
财政年份:
2014
资助国家:
加拿大
项目状态:
已结题
起止时间:
2014-01-01 至 2015-12-31

项目摘要

项目成果

Annabi, Borhane的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Laboratory of Molecular Oncology at the Université du Québec à Montréal (UQAM) and under the direction of Professor Borhane Annabi is partnering with AngioChem a Montreal-based company reknown for its unique synthetic strategies applicable to breakthrough pharmacological agents that are optimized to cross the blood-brain barrier (BBB). Such technology will help to better understand molecular and cellular processes involved in central nervous system and brain-related disorders. The current project will investigate the molecular mechanisms involved in intracellular low-density lipoprotein receptor-related protein (LRP)-1 receptor-dependent and independent pathways. Such pathways open up a wide variety of original and sophisticated molecular strategies to explore new and original molecular and cellular processes involved in processes such as angiogenesis and impact of hypoxia (low oxygen levels) on cells and tissues. The current proposed collaborative project is designed to identify and investigate the alternate receptors and/or interacting molecular partners that could be involved in the transport of Angiopeps. This will result in an increased fundamental understanding of the LRP-1 transport mechanisms that will enable novel chemical entities to target critical cellular processes such as those involved in uncontrolled carcinogenic cell proliferation, cell survival, as well as those mechanisms involved in tumour-associated angiogenesis, and in brain-related disorders. The expected benefits will help to accrue to Canadian industry and to UQAM, the targeted areas under investigation in the described joint research and development activities are expected to leverage a breakthrough platform technology enabling physiological transport of bioactive molecules across the BBB. As such, AngioChem currently positions itself as the leader in this field. Academically, the direct benefits to UQAM include valuable training opportunities, increased employment as well as anchoring exciting industrial partnerships to the Montreal region. Scientifically, UQAM's Faculty of Sciences will enormously benefit of increased visibility from such an active partnership.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Probing into receptor-mediated trafficking and internalization functions of biologically active peptides
  • 批准号:
    RGPIN-2018-06651
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.62万
  • 财政年份:
    2022
  • 负责人:
    Annabi, Borhane
  • 依托单位:
Probing into receptor-mediated trafficking and internalization functions of biologically active peptides
  • 批准号:
    RGPIN-2018-06651
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.62万
  • 财政年份:
    2021
  • 负责人:
    Annabi, Borhane
  • 依托单位:
Probing into receptor-mediated trafficking and internalization functions of biologically active peptides
  • 批准号:
    RGPIN-2018-06651
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.62万
  • 财政年份:
    2020
  • 负责人:
    Annabi, Borhane
  • 依托单位:
Probing into receptor-mediated trafficking and internalization functions of biologically active peptides
  • 批准号:
    RGPIN-2018-06651
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.62万
  • 财政年份:
    2019
  • 负责人:
    Annabi, Borhane
  • 依托单位:
海外基金